Stable duplex-linked antisense targeting miR-148a inhibits breast cancer cell proliferation

Area of Science:

• Molecular Biology
• Cancer Research
• Gene Regulation

Background:

• MicroRNAs (miRNAs) are key regulators of gene expression, influencing cellular processes like proliferation.
• MicroRNA-148a (miR-148a) is notably downregulated in breast cancer (BC), suggesting a potential role in tumorigenesis.
• The functional implications of low miR-148a levels and its sequestration in BC remain underexplored.

Purpose of the Study:

• To investigate the effect of miR-148a knockdown on breast cancer cell proliferation.
• To determine if specific anti-miRNA oligonucleotide (AMO) designs can effectively sequester miR-148a.
• To identify downstream targets of miR-148a and elucidate its mechanism in BC.

Main Methods:

• Knockdown of miR-148a using various anti-miRNA oligonucleotide (AMO) designs, including interstrand cross-linked duplexes (CL-AMO).
• Assessment of breast cancer cell proliferation rates following miR-148a inhibition.
• Quantitative analysis of miR-148a and miR-148b levels, and thioredoxin-interacting protein (TXNIP) mRNA expression.

Main Results:

• Cross-linked duplex AMOs (CL-AMO) significantly suppressed breast cancer cell proliferation, unlike other AMO types.
• The observed suppression was specific to miR-148a, with no effect on miR-148b.
• miR-148a downregulation led to a more potent and sustained inhibition of proliferation compared to targeting miR-21.
• Thioredoxin-interacting protein (TXNIP), a tumor suppressor, was identified as a direct target of miR-148a, and its mRNA expression increased upon CL-AMO treatment.

Conclusions:

• Lowly expressed miR-148a functions as an oncogene in breast cancer.
• Specific sequestration of miR-148a using CL-AMOs effectively inhibits BC proliferation.
• miR-148a and its target TXNIP represent a promising therapeutic avenue for breast cancer treatment.